MGLIX
Price
$15.76
Change
-$0.01 (-0.06%)
Updated
Apr 25 closing price
Net Assets
2.21B
NGJCX
Price
$18.22
Change
-$0.03 (-0.16%)
Updated
Apr 25 closing price
Net Assets
44.51M
Ad is loading...

MGLIX vs NGJCX

Header iconMGLIX vs NGJCX Comparison
Open Charts MGLIX vs NGJCXBanner chart's image
MFS Global Real Estate I
Price$15.76
Change-$0.01 (-0.06%)
VolumeN/A
Net Assets2.21B
Nuveen Global Real Estate Securities C
Price$18.22
Change-$0.03 (-0.16%)
VolumeN/A
Net Assets44.51M
MGLIX vs NGJCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MGLIX vs. NGJCX commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGLIX is a Buy and NGJCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
MGLIX has more cash in the bank: 2.21B vs. NGJCX (44.5M). MGLIX pays higher dividends than NGJCX: MGLIX (2.61) vs NGJCX (2.13). MGLIX was incepted earlier than NGJCX: MGLIX (16 years) vs NGJCX (7 years). NGJCX (2.58) is less costly to investors than MGLIX (0.95). NGJCX is a more actively managed with annual turnover of: 81.00 vs. MGLIX (48.00). MGLIX has a lower initial minimum investment than NGJCX: MGLIX (0) vs NGJCX (3000). NGJCX annual gain was more profitable for investors over the last year : 9.67 vs. MGLIX (3.86). MGLIX return over 5 years is better than : 22.59 vs. NGJCX (18.51).
MGLIXNGJCXMGLIX / NGJCX
Total Expense Ratio0.942.0546%
Annual Report Gross Expense Ratio0.952.5837%
Fund Existence16 years7 years-
Gain YTD-1.6831.682-100%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.21B44.5M4,964%
Annual Yield % from dividends2.612.13123%
Returns for 1 year3.869.6740%
Returns for 3 years-19.39-12.53155%
Returns for 5 years22.5918.51122%
Returns for 10 years20.06N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JFNAX65.010.10
+0.15%
Janus Henderson Global Life Sciences A
TOCQX44.17N/A
N/A
Tocqueville
GMVRX14.65N/A
N/A
Goldman Sachs Small/Mid Cap Value R
NSFOX10.39N/A
N/A
Natixis Target Retirement 2065 N
GTDIX33.24N/A
N/A
Invesco EQV Emerging Markets All Cap R5